Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium vivax | ferlin, putative | 0.0029 | 0 | 0.5 |
Onchocerca volvulus | Putative cc2d1b protein | 0.0029 | 0 | 0.5 |
Echinococcus granulosus | fatty acid amide hydrolase 1 | 0.0237 | 0.6748 | 0.6748 |
Echinococcus granulosus | fatty acid amide hydrolase 1 | 0.0237 | 0.6748 | 0.6748 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | synaptotagmin 1,2, putative | 0.0029 | 0 | 0.5 |
Trypanosoma brucei | cAMP binding protein, putative | 0.0029 | 0 | 0.5 |
Trypanosoma cruzi | Coiled-coil and C2 domain-containing protein | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | synaptotagmin, putative | 0.0029 | 0 | 0.5 |
Toxoplasma gondii | Sma protein | 0.0029 | 0 | 0.5 |
Entamoeba histolytica | C2 domain containing protein | 0.0029 | 0 | 0.5 |
Toxoplasma gondii | C2 domain-containing protein | 0.0029 | 0 | 0.5 |
Trypanosoma brucei | predicted C2 domain protein | 0.0029 | 0 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0029 | 0 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0029 | 0 | 0.5 |
Leishmania major | c2 domain protein, putative | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | synaptotagmin, putative | 0.0029 | 0 | 0.5 |
Plasmodium falciparum | ferlin, putative | 0.0029 | 0 | 0.5 |
Onchocerca volvulus | Multiple C2 domain and transmembrane region protein homolog | 0.0029 | 0 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | ion channel nompc, putative | 0.0029 | 0 | 0.5 |
Plasmodium vivax | double C2-like domain-containing protein, putative | 0.0029 | 0 | 0.5 |
Plasmodium vivax | ferlin, putative | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0029 | 0 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0029 | 0 | 0.5 |
Trypanosoma brucei | predicted C2 domain protein | 0.0029 | 0 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0029 | 0 | 0.5 |
Echinococcus multilocularis | retinoic acid receptor rxr beta a retinoic acid receptor rxr alpha a retinoic acid receptor rxr alpha | 0.0325 | 0.9587 | 1 |
Toxoplasma gondii | ferlin family protein | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | synaptotagmin 1, 3, C.elegans, putative | 0.0029 | 0 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0029 | 0 | 0.5 |
Trypanosoma cruzi | synaptotagmin, putative | 0.0029 | 0 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0029 | 0 | 0.5 |
Plasmodium falciparum | conserved Plasmodium protein, unknown function | 0.0029 | 0 | 0.5 |
Toxoplasma gondii | hypothetical protein | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | copine, putative | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0029 | 0 | 0.5 |
Entamoeba histolytica | C2 domain containing protein | 0.0029 | 0 | 0.5 |
Toxoplasma gondii | hypothetical protein | 0.0029 | 0 | 0.5 |
Schistosoma mansoni | fatty-acid amide hydrolase | 0.0237 | 0.6748 | 0.6748 |
Trichomonas vaginalis | synaptotagmin, putative | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0029 | 0 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | copine, putative | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | copine, putative | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | synaptotagmin, putative | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | synaptotagmin, putative | 0.0029 | 0 | 0.5 |
Leishmania major | c2 domain protein, putative | 0.0029 | 0 | 0.5 |
Trypanosoma brucei | C2 domain containing protein, putative | 0.0029 | 0 | 0.5 |
Entamoeba histolytica | DENN domain protein | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0029 | 0 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0029 | 0 | 0.5 |
Trypanosoma cruzi | phosphoinositide-specific phospholipase C, putative | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | copine, putative | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | ankyrin repeat-containing protein, putative | 0.0029 | 0 | 0.5 |
Entamoeba histolytica | C2 domain containing protein | 0.0029 | 0 | 0.5 |
Trypanosoma brucei | C2 domain containing protein, putative | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0029 | 0 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0029 | 0 | 0.5 |
Trypanosoma brucei | phosphoinositide-specific phospholipase C | 0.0029 | 0 | 0.5 |
Entamoeba histolytica | hypothetical protein, conserved | 0.0029 | 0 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | Circumsporozoite protein precursor, putative | 0.0029 | 0 | 0.5 |
Onchocerca volvulus | 0.0029 | 0 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.0237 | 0.6748 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | copine, putative | 0.0029 | 0 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.0029 | 0 | 0.5 |
Plasmodium falciparum | ferlin, putative | 0.0029 | 0 | 0.5 |
Trypanosoma brucei | C2 domain/Ankyrin repeats (3 copies), putative | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0029 | 0 | 0.5 |
Trypanosoma cruzi | cAMP binding protein, putative | 0.0029 | 0 | 0.5 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0029 | 0 | 0.5 |
Trypanosoma cruzi | cytoskeleton associated protein, putative | 0.0029 | 0 | 0.5 |
Entamoeba histolytica | C2 domain containing protein | 0.0029 | 0 | 0.5 |
Entamoeba histolytica | protein kinase, putative | 0.0029 | 0 | 0.5 |
Echinococcus multilocularis | fatty acid amide hydrolase 1 | 0.0237 | 0.6748 | 0.7038 |
Entamoeba histolytica | hypothetical protein | 0.0029 | 0 | 0.5 |
Trypanosoma brucei | predicted C2 domain protein | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | synaptotagmin, putative | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0029 | 0 | 0.5 |
Entamoeba histolytica | Rap/Ran GTPase activating protein, putative | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | synaptotagmin 1,2, putative | 0.0029 | 0 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | synaptotagmin 1, 3, C.elegans, putative | 0.0029 | 0 | 0.5 |
Trypanosoma cruzi | C2 domain containing protein, putative | 0.0029 | 0 | 0.5 |
Echinococcus multilocularis | fatty acid amide hydrolase 1 | 0.0237 | 0.6748 | 0.7038 |
Trichomonas vaginalis | Proline-rich protein, putative | 0.0029 | 0 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | splicing factor 3A subunit, putative | 0.0029 | 0 | 0.5 |
Trypanosoma brucei | C2 domain containing protein, putative | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | calcium-dependent lipid-binding protein, putative | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | vab10 spectraplakin, putative | 0.0029 | 0 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0029 | 0 | 0.5 |
Onchocerca volvulus | 0.0029 | 0 | 0.5 | |
Trichomonas vaginalis | conserved hypothetical protein | 0.0029 | 0 | 0.5 |
Leishmania major | phospholipase c-like protein | 0.0029 | 0 | 0.5 |
Leishmania major | copine i-like protein | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0029 | 0 | 0.5 |
Onchocerca volvulus | 0.0029 | 0 | 0.5 | |
Trypanosoma cruzi | synaptotagmin, putative | 0.0029 | 0 | 0.5 |
Entamoeba histolytica | protein kinase, putative | 0.0029 | 0 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0029 | 0 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0029 | 0 | 0.5 |
Entamoeba histolytica | C2 domain containing protein | 0.0029 | 0 | 0.5 |
Trypanosoma brucei | synaptotagmin, putative | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | annexin VII, putative | 0.0029 | 0 | 0.5 |
Onchocerca volvulus | 0.0029 | 0 | 0.5 | |
Toxoplasma gondii | hypothetical protein | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0029 | 0 | 0.5 |
Entamoeba histolytica | C2 domain containing protein | 0.0029 | 0 | 0.5 |
Onchocerca volvulus | 0.0029 | 0 | 0.5 | |
Toxoplasma gondii | phosphoinositide phospholipase PIPLC | 0.0029 | 0 | 0.5 |
Onchocerca volvulus | 0.0029 | 0 | 0.5 | |
Trypanosoma brucei | Coiled-coil and C2 domain-containing protein | 0.0029 | 0 | 0.5 |
Entamoeba histolytica | hypothetical protein, conserved | 0.0029 | 0 | 0.5 |
Entamoeba histolytica | C2 domain protein, putative | 0.0029 | 0 | 0.5 |
Entamoeba histolytica | calcium-binding protein, putative | 0.0029 | 0 | 0.5 |
Entamoeba histolytica | C2 domain containing protein | 0.0029 | 0 | 0.5 |
Onchocerca volvulus | 0.0029 | 0 | 0.5 | |
Trypanosoma brucei | C2 domain containing protein, putative | 0.0029 | 0 | 0.5 |
Trypanosoma cruzi | cytoskeleton associated protein, putative | 0.0029 | 0 | 0.5 |
Entamoeba histolytica | C2 domain containing protein | 0.0029 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0029 | 0 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0029 | 0 | 0.5 |
Entamoeba histolytica | C2 domain containing protein | 0.0029 | 0 | 0.5 |
Toxoplasma gondii | Elicitor-responsive protein, putative | 0.0029 | 0 | 0.5 |
Schistosoma mansoni | retinoic acid receptor RXR | 0.0337 | 1 | 1 |
Onchocerca volvulus | 0.0029 | 0 | 0.5 | |
Trichomonas vaginalis | synaptotagmin, putative | 0.0029 | 0 | 0.5 |
Trypanosoma cruzi | C2 domain/Ankyrin repeats (3 copies), putative | 0.0029 | 0 | 0.5 |
Plasmodium falciparum | double C2-like domain-containing protein | 0.0029 | 0 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0029 | 0 | 0.5 |
Brugia malayi | amidase | 0.0237 | 0.6748 | 1 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0029 | 0 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0029 | 0 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0029 | 0 | 0.5 |
Schistosoma mansoni | amidase | 0.0237 | 0.6748 | 0.6748 |
Trichomonas vaginalis | synaptotagmin 1,2, putative | 0.0029 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (binding) | = 0 % | Percent inhibition of [3H]-LTB4 binding to guinea pig spleen Leukotriene B4 receptor at the concentration of 10e-5 M | ChEMBL. | 1324316 |
Inhibition (binding) | = 0 % | Percent inhibition of [3H]-LTB4 binding to guinea pig spleen Leukotriene B4 receptor at the concentration of 10e-5 M | ChEMBL. | 1324316 |
Inhibition (binding) | = 25 % | Tested for 50% inhibition of LTA4 hydrolase at 2*10e-5M concentration in porcine leukocyte homogenates | ChEMBL. | 1324316 |
Inhibition (binding) | = 25 % | Tested for 50% inhibition of LTA4 hydrolase at 2*10e-5M concentration in porcine leukocyte homogenates | ChEMBL. | 1324316 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.